BRCA1 and breast cancer: Additionally, the high prevalence of BC and the presence of frequent of BRCA1 mutations emphasize the need for improving screening programs and individual testing/counselling a part of screening policies in North African populations though it will be important to find the appropriate compromise between this strategy and the economic constraints inherent to these countries.